Safety and Efficacy of Etrasimod (APD334) in Patients With Ulcerative Colitis
Public ClinicalTrials.gov record NCT02447302. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Study to Investigate the Safety and Efficacy of APD334 in Patients With Moderately to Severely Active Ulcerative Colitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine whether etrasimod is a safe and effective treatment for ulcerative colitis.
Study identification
- NCT ID
- NCT02447302
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 156 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 15, 2015 (Actual)
- Primary completion
- Feb 14, 2018 (Actual)
- Completion
- Feb 14, 2018 (Actual)
- Last update posted
- Apr 5, 2021
2015 – 2018
United States locations
- U.S. sites
- 30
- U.S. states
- 15
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arena 1119 | Birmingham | Alabama | 35294 | — |
| Arena 1133 | Dothan | Alabama | 36305 | — |
| Arena 1143 | Thousand Oaks | California | 91360 | — |
| Arena 1107 | Hollywood | Florida | 33021 | — |
| Arena 1138 | Miami | Florida | 33134 | — |
| Arena 1123 | Naples | Florida | 34102 | — |
| Arena 1141 | Orlando | Florida | 32825 | — |
| Arena 1106 | Port Orange | Florida | 32127 | — |
| Arena 1137 | Sweetwater | Florida | 33172 | — |
| Arena 1131 | Chicago | Illinois | 60611 | — |
| Arena 1139 | Hoffman Estates | Illinois | 60169 | — |
| Arena 1127 | Urbana | Illinois | 61801 | — |
| Arena 1142 | Traverse City | Michigan | 49686 | — |
| Arena 1111 | Troy | Michigan | 48098 | — |
| Arena 1109 | Great Neck | New York | 11021 | — |
| Arena 1114 | Rochester | New York | 14642 | — |
| Arena 1118 | Raleigh | North Carolina | 27612 | — |
| Arena 1112 | Cincinnati | Ohio | 45267 | — |
| Arena 1117 | Pittsburgh | Pennsylvania | 15219 | — |
| Arena 1105 | Germantown | Tennessee | 38138 | — |
| Arena 1102 | Hermitage | Tennessee | 37076 | — |
| Arena 1136 | DeSoto | Texas | 75115 | — |
| Arena 1121 | Houston | Texas | 77030 | — |
| Arena 1116 | Temple | Texas | 76508 | — |
| Arena 1103 | Ogden | Utah | 84405 | — |
| Arena 1130 | Richmond | Virginia | 23298 | — |
| Arena 1128 | Roanoke | Virginia | 24014 | — |
| Arena 1115 | Seattle | Washington | 98101 | — |
| Arena 1101 | Seattle | Washington | 98195 | — |
| Arena 1108 | Wauwatosa | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 104 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02447302, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 5, 2021 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02447302 live on ClinicalTrials.gov.